Source:http://linkedlifedata.com/resource/pubmed/id/12745412
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2003-5-14
|
pubmed:abstractText |
The function of the central alpha-adrenergic, serotoninergic and dopaminergic systems was investigated in 30 heroin-dependent subjects, 6 - 8 weeks after detoxification and in 22 psychophysically healthy controls (group C). Twelve heroin-dependent subjects with antisocial personality disorder (ASPD) (group A), 18 heroin-dependent subjects without other Axis I and II pathologies (group B) were included among abstinent substance abusers. The norepinephrine (NE) function was evaluated by the GH responses to acute stimulation with clonidine (clon); the serotonin (5-HT) function by the PRL and cortisol (CORT) responses to acute stimulation with d-fenfluramine (d-fen) and the dopamine (DA) function was investigated by growth hormone (GH) and prolactin (PRL) responses to acute administration of bromocriptine (brom). Alpha-adrenergic sensitivity, as measured by the GH-clon test, was found significantly reduced in A subjects (ASPD), in comparison with B subjects and controls. PRL and CORT responses to d-fen were significantly blunted both in A and B subjects, in comparison with control subjects. DA receptors sensitivity seems to be reduced significantly in ASPD (A subjects); in contrast, heroin addicts without open psychiatric co-morbidity showed unimpaired responses to brom challenge; a significantly lower GH response to brom and a lack of PRL suppression in ASPD subjects could express D2 postsynaptic receptor hyposensitivity possibly related to DA gene variants associated to co-morbid disorder. In sum, the study of central monoamine function revealed an alteration of the 5-HT system in all detoxified heroin-dependent subjects. A significant reduction of alpha-adrenergic receptors sensitivity and the hyposensitivity of postsynaptic DA receptors in ASPD subjects suggest once again that specific biological correlates of psychiatric co-morbidity may characterize substance abusers subtypes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Bromocriptine,
http://linkedlifedata.com/resource/pubmed/chemical/Clonidine,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Fenfluramine,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Agents
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1355-6215
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
23-32
|
pubmed:dateRevised |
2007-3-27
|
pubmed:meshHeading |
pubmed-meshheading:12745412-Adrenergic alpha-Agonists,
pubmed-meshheading:12745412-Adult,
pubmed-meshheading:12745412-Antisocial Personality Disorder,
pubmed-meshheading:12745412-Brain,
pubmed-meshheading:12745412-Bromocriptine,
pubmed-meshheading:12745412-Case-Control Studies,
pubmed-meshheading:12745412-Clonidine,
pubmed-meshheading:12745412-Dopamine,
pubmed-meshheading:12745412-Dopamine Agonists,
pubmed-meshheading:12745412-Fenfluramine,
pubmed-meshheading:12745412-Heroin Dependence,
pubmed-meshheading:12745412-Humans,
pubmed-meshheading:12745412-Male,
pubmed-meshheading:12745412-Neurosecretory Systems,
pubmed-meshheading:12745412-Norepinephrine,
pubmed-meshheading:12745412-Serotonin,
pubmed-meshheading:12745412-Serotonin Agents
|
pubmed:year |
2003
|
pubmed:articleTitle |
Neuroendocrine correlates of antisocial personality disorder in abstinent heroin-dependent subjects.
|
pubmed:affiliation |
Centro Studi Farmaco-tossicopendenze, Ser T, Ausl, Parma, Italy. ggerra@ausl.pr.it
|
pubmed:publicationType |
Journal Article
|